Literature DB >> 27776293

Converging effects of diverse treatment modalities on frontal cortex in schizophrenia: A review of longitudinal functional magnetic resonance imaging studies.

Ayse Sakalli Kani1, Ann K Shinn2, Kathryn E Lewandowski2, Dost Öngür3.   

Abstract

OBJECTIVES: A variety of treatment options exist for schizophrenia, but the effects of these treatments on brain function are not clearly understood. To facilitate the development of more effective treatment strategies, it is important to identify how brain function in schizophrenia patients is affected by the diverse therapeutic approaches that are currently available. The aim of the present article is to systematically review the evidence for functional brain changes associated with different treatment modalities for schizophrenia.
METHODS: We searched PubMed for longitudinal functional MRI (fMRI) studies reporting on the effects of antipsychotic medications (APM), repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), cognitive remediation therapy (CRT) and cognitive behavioral therapy for psychosis (CBTp) on brain function in schizophrenia.
RESULTS: Thirty six studies fulfilled the inclusion criteria. Functional alterations were observed in diverse brain regions. Across intervention modalities, changes in fMRI parameters were reported most commonly in frontal brain regions including prefrontal cortex, anterior cingulate and inferior frontal cortex.
CONCLUSIONS: We conclude that current treatments for schizophrenia commonly induce functional brain alterations in frontal brain regions. However, interpretability is limited by inconsistency in task and region of interest selection, and failures to replicate. Further task independent fMRI studies examining treatment effects with whole brain analysis are needed to deepen our insights. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antipsychotic; Brain function; CBTp; CRT; Schizophrenia; fMRI; rTMS; tDCS

Mesh:

Year:  2016        PMID: 27776293      PMCID: PMC5135290          DOI: 10.1016/j.jpsychires.2016.10.012

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  95 in total

1.  Restoration of frontal activation during a treatment with quetiapine: an fMRI study of blunted affect in schizophrenia.

Authors:  Emmanuel Stip; Cherine Fahim; Adham Mancini-Marïe; Lahcen Ait Bentaleb; Boualem Mensour; Adrianna Mendrek; Mario Beauregard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-11-05       Impact factor: 5.067

2.  Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.

Authors:  Beth E Snitz; Angus MacDonald; Jonathan D Cohen; Raymond Y Cho; Theresa Becker; Cameron S Carter
Journal:  Am J Psychiatry       Date:  2005-12       Impact factor: 18.112

3.  Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia.

Authors:  Nicoletta M J van Veelen; Matthijs Vink; Nick F Ramsey; Mariët van Buuren; Janna Marie Hoogendam; René S Kahn
Journal:  Schizophr Res       Date:  2011-04-15       Impact factor: 4.939

4.  Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia.

Authors:  Karuna Subramaniam; Tracy L Luks; Melissa Fisher; Gregory V Simpson; Srikantan Nagarajan; Sophia Vinogradov
Journal:  Neuron       Date:  2012-02-23       Impact factor: 17.173

5.  Multimodal Applications of Transcranial Magnetic Stimulation for Circuit-Based Psychiatry.

Authors:  Joan A Camprodon; Alvaro Pascual-Leone
Journal:  JAMA Psychiatry       Date:  2016-04       Impact factor: 21.596

6.  Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations.

Authors:  Giorgio Chibbaro; Marco Daniele; Giovanna Alagona; Concetta Di Pasquale; Michele Cannavò; Vincenzo Rapisarda; Rita Bella; Giovanni Pennisi
Journal:  Neurosci Lett       Date:  2005-04-15       Impact factor: 3.046

7.  Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises.

Authors:  B E Wexler; M Anderson; R K Fulbright; J C Gore
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

Review 8.  Frontal lobe dysfunctions in schizophrenia--II. Impairments of psychological and brain functions.

Authors:  S Levin
Journal:  J Psychiatr Res       Date:  1984       Impact factor: 4.791

9.  Transcranial magnetic stimulation of Wernicke's and Right homologous sites to curtail "voices": a randomized trial.

Authors:  Ralph E Hoffman; Kun Wu; Brian Pittman; John D Cahill; Keith A Hawkins; Thomas Fernandez; Jonas Hannestad
Journal:  Biol Psychiatry       Date:  2013-02-26       Impact factor: 13.382

10.  Effects on the brain of a psychological treatment: cognitive remediation therapy: functional magnetic resonance imaging in schizophrenia.

Authors:  Til Wykes; Michael Brammer; John Mellers; Peter Bray; Clare Reeder; Clare Williams; Julia Corner
Journal:  Br J Psychiatry       Date:  2002-08       Impact factor: 9.319

View more
  13 in total

Review 1.  Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies.

Authors:  Goda Tarcijonas; Deepak K Sarpal
Journal:  Neurobiol Dis       Date:  2018-06-25       Impact factor: 5.996

2.  Multivariate Associations Among Behavioral, Clinical, and Multimodal Imaging Phenotypes in Patients With Psychosis.

Authors:  Dominik A Moser; Gaelle E Doucet; Won Hee Lee; Alexander Rasgon; Hannah Krinsky; Evan Leibu; Alex Ing; Gunter Schumann; Natalie Rasgon; Sophia Frangou
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

3.  Frontolimbic affective bias and false narratives from brain disease.

Authors:  Mario F Mendez
Journal:  Med Hypotheses       Date:  2019-04-29       Impact factor: 1.538

4.  A Functional Neuroimaging Meta-Analysis of Self-Related Processing in Schizophrenia.

Authors:  Stéphane Potvin; Lydia Gamache; Ovidiu Lungu
Journal:  Front Neurol       Date:  2019-09-11       Impact factor: 4.003

Review 5.  Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia.

Authors:  Jason Smucny; Samuel J Dienel; David A Lewis; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2021-07-20       Impact factor: 7.853

Review 6.  The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies.

Authors:  Chengmin Yang; Jing Tang; Naici Liu; Li Yao; Mengyuan Xu; Hui Sun; Bo Tao; Qiyong Gong; Hengyi Cao; Wenjing Zhang; Su Lui
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

7.  Schizophrenia-Like Behavioral Impairments in Mice with Suppressed Expression of Piccolo in the Medial Prefrontal Cortex.

Authors:  Atsumi Nitta; Naotaka Izuo; Kohei Hamatani; Ryo Inagaki; Yuka Kusui; Kequan Fu; Takashi Asano; Youta Torii; Chikako Habuchi; Hirotaka Sekiguchi; Shuji Iritani; Shin-Ichi Muramatsu; Norio Ozaki; Yoshiaki Miyamoto
Journal:  J Pers Med       Date:  2021-06-26

8.  Etiological Beliefs, Treatments, Stigmatizing Attitudes toward Schizophrenia. What Do Italians and Israelis Think?

Authors:  Stefania Mannarini; Marilisa Boffo; Alessandro Rossi; Laura Balottin
Journal:  Front Psychol       Date:  2018-01-09

Review 9.  The Role of Working Memory for Cognitive Control in Anorexia Nervosa versus Substance Use Disorder.

Authors:  Samantha J Brooks; Sabina G Funk; Susanne Y Young; Helgi B Schiöth
Journal:  Front Psychol       Date:  2017-09-22

10.  Effects of transcranial direct current stimulation on working memory and negative symptoms in schizophrenia: a phase II randomized sham-controlled trial.

Authors:  J S Gomes; A P Trevizol; D V Ducos; A Gadelha; B B Ortiz; A O Fonseca; H T Akiba; C C Azevedo; L S P Guimaraes; P Shiozawa; Q Cordeiro; A Lacerda; A M Dias
Journal:  Schizophr Res Cogn       Date:  2018-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.